Elevance Health, Inc. (ELV)

Elevance Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Premiums & Annuity Revenue	164,639	144,166	142,854	133,229	117,373
Total Interest & Dividend Income	2,194	2,051	1,825	1,485	1,378
Other Revenue	32,292	30,593	26,661	21,885	19,892
Total Revenue	199,125	176,810	171,340	156,599	138,643
Revenue Growth (YoY)	12.62%	3.19%	9.41%	12.95%	13.76%
Policy Benefits	148,223	127,567	124,330	116,642	102,571
Amortization of Goodwill & Intangibles	628	580	885	767	441
Selling, General & Administrative	41,940	39,466	36,236	30,728	26,604
Total Operating Expenses	190,791	167,613	161,451	148,137	129,616
Operating Income	8,334	9,197	9,889	8,462	9,027
Interest Expense	-1,402	-1,185	-1,030	-855	-802
EBT Excluding Unusual Items	6,932	8,012	8,859	7,607	8,225
Merger & Restructuring Charges	-198	-268	-752	-7	-202
Gain (Loss) on Sale of Assets	-	201	-	-	-
Asset Writedown	-	-41	-392	-	-7
Legal Settlements	-24	-	-	-	-
Other Unusual Items	-	-	-	-	-21
Pretax Income	6,710	7,904	7,715	7,600	7,995
Income Tax Expense	1,049	1,933	1,724	1,712	1,846
Earnings From Continuing Ops.	5,661	5,971	5,991	5,888	6,149
Minority Interest in Earnings	1	9	-4	6	9
Net Income	5,662	5,980	5,987	5,894	6,158
Net Income to Common	5,662	5,980	5,987	5,894	6,158
Net Income Growth	-5.32%	-0.12%	1.58%	-4.29%	34.69%
Shares Outstanding (Basic)	225	232	236	240	244
Shares Outstanding (Diluted)	225	233	237	243	247
Shares Change (YoY)	-3.56%	-1.90%	-2.22%	-1.62%	-2.95%
EPS (Basic)	25.21	25.81	25.38	24.56	25.26
EPS (Diluted)	25.21	25.68	25.22	24.28	24.95
EPS Growth	-1.83%	1.82%	3.87%	-2.69%	38.77%
Free Cash Flow	3,174	4,552	6,765	7,247	7,277
Free Cash Flow Per Share	14.13	19.55	28.50	29.85	29.48
Dividend Per Share	6.840	6.520	5.920	5.120	4.520
Dividend Growth	4.91%	10.13%	15.63%	13.27%	18.95%
Operating Margin	4.18%	5.20%	5.77%	5.40%	6.51%
Profit Margin	2.84%	3.38%	3.49%	3.76%	4.44%
Free Cash Flow Margin	1.59%	2.57%	3.95%	4.63%	5.25%
EBITDA	9,880	9,856	10,949	9,538	9,844
EBITDA Margin	4.96%	5.57%	6.39%	6.09%	7.10%
D&A For EBITDA	1,546	659	1,060	1,076	817
EBIT	8,334	9,197	9,889	8,462	9,027
EBIT Margin	4.18%	5.20%	5.77%	5.40%	6.51%
Effective Tax Rate	15.63%	24.46%	22.35%	22.53%	23.09%
Revenue as Reported	199,125	177,011	171,340	156,595	138,639

Updated Jan 28, 2026. Source: S&P Global Market Intelligence. Insurance template. Financial Sources.

SEC Filings: 10-K · 10-Q